Summary
JAN Chart
Janus Living: After Recent IPO, Senior-Care REIT Goes On Property Shopping Spree
Janus Living, recently spun off from Healthpeak Properties, presents a new REIT opportunity in the senior-living sector. JAN benefits from Healthpeak's external management and affiliation, potentially enhancing its competitive positioning among senior care REIT peers. Key investment considerations include top-line growth drivers, margin trends, balance sheet strength, and dividend dynamics relative to sector peers.
Janus Living, Inc. (JAN) Q1 2026 Earnings Call Transcript
Janus Living, Inc. (JAN) Q1 2026 Earnings Call Transcript
JAN Q1 Earnings Call Highlights
Janus Living Inc. JAN NYSE: JAN used its inaugural earnings call as a standalone public company to highlight a strong first quarter of 2026, a debt-free balance sheet and an acquisition pipeline that management said could materially expand the senior housing REIT's portfolio.
JanOne Inc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 George Soros Soros Fund Management LLC | 228,768 | $5.39M | $5.39M | - | - |
 Chris Davis Davis Selected Advisers | 10,000 | $235,700 | $235,700 | - | - |
 Point72 Asset Management LP Point72 Asset Management LP | 101,419 | $2.39M | $2.39M | - | - |
 Joseph Castro Nuveen LLC | 1.43M | $33.6M | $33.6M | - | - |
| RO Regan O'Neill Burkehill Global Management LP | 650,000 | $15.32M | $15.32M | - | - |
JanOne Inc (JAN) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
JanOne Inc Profile
| Biotechnology Industry | Healthcare Sector | Scott Brinker CEO | NASDAQ (CM) Exchange | 471024109 CUSIP |
| US Country | 5 Employees | 24 Jun 2026 Last Dividend | 22 Apr 2019 Last Split | 7 Nov 1991 IPO Date |
Overview
JanOne Inc. is a clinical-stage biopharmaceutical company dedicated to the advancement of non-opioid and non-addictive treatments aimed at addressing the critical unmet medical needs in pain management and addiction. With a dynamic approach that includes identifying, acquiring, licensing, developing, partnering, and commercializing innovative therapies, JanOne stands at the forefront of addressing the global challenges of pain and addiction. Established in 1976 and undergoing a significant transformation from Appliance Recycling Centers of America, Inc. to JanOne Inc. in September 2019, the company showcases a unique blend of expertise in biotechnology and recycling services. Headquartered in Las Vegas, Nevada, JanOne's unique operational model is divided into two core segments: Biotechnology and Recycling, illustrating its diversified interests and capabilities beyond biopharmaceuticals.
Products and Services
- JAN101
- Appliance Recycling and Replacement Services
As JanOne Inc.'s flagship product candidate, JAN101 epitomizes the company's innovative approach to healthcare. This patented oral and sustained release pharmaceutical composition of sodium nitrite directly targets poor blood flow to the extremities, a common complication in patients with diabetes or peripheral artery disease. By focusing on improving blood flow, JAN101 aims to alleviate pain, addressing a significant gap in current treatment options for these conditions without resorting to opioids or addictive substances.
Reflecting JanOne's roots and continued commitment to environmental sustainability, the company offers comprehensive appliance recycling and replacement services. These services are designed for utilities and sponsors of energy efficiency programs, providing an environmentally friendly solution to appliance disposal. Through these efforts, JanOne contributes to the reduction of waste and the promotion of energy efficiency, demonstrating the company's dedication to environmental stewardship alongside its focus on healthcare innovation.
